|He then set up and grew Nomura’s in-house lifesciences and healthcare services private equity groups, before joining Mizuho International to establish its first non-Japanese private equity group in 2005. In 2006, David led the spin out of this group to form Apposite.
David is very involved in the UK healthcare industry, and has served as a member of the UK government’s Health Reform Group looking at reforms to the provision of healthcare to NHS patients. David also served on the finance section of the UK Bioscience Innovation and Growth Team review. David was Chairman of the Audit Committee and Board Member of the BioIndustry Association.
Please see www.apposite-capital.com for more information.
|Download [ Audio File (56 MB)] [ Text Transcript (87 KB)]|